In addition, the emerging findings investigating the clinical implications of ACE2, TMPRSS2, and NRP1 expression on renal cancer cells for RCC treatment, and the prognostic significance of gene signatures related to SARS-CoV-2 infection in renal cancer cell patients will be reviewed. This evidence concerns the gene TMPRSS2 and renal cell carcinoma.